The 20 Best COVID-19 Doctors Near Me in Baltimore, MD

Daniel Brodie is an Intensive Care Medicine specialist and a Pulmonary Medicine provider practicing medicine in Baltimore, Maryland. Dr. Brodie is rated as a Distinguished provider by MediFind in the treatment of COVID-19. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Acute Respiratory Distress Syndrome (ARDS), COVID-19, Respiratory Acidosis, Embolectomy, and Lung Transplant. Dr. Brodie is board certified in American Board Of Internal Medicine.

Dr. Hager is a specialist in Critical Care Medicine. He is an expert in the diagnosis and management of all forms of acute respiratory failure, including asthma, pneumonia, C.O.P.D., neuromuscular diseases, and the acute respiratory distress syndrome. He also has extensive experience in the management of other life-threatening conditions such as pulmonary embolism, gastrointestinal hemorrhage, shock from sepsis, hypovolemia, and heart disease, and metabolic emergencies such as diabetic ketoacidosis and hyperosmolar states. Dr. Hager is rated as a Distinguished provider by MediFind in the treatment of COVID-19. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Severe Acute Respiratory Syndrome (SARS), COVID-19, Cerebral Hypoxia, and Acute Respiratory Distress Syndrome (ARDS). Dr. Hager is board certified in American Board Of Internal Medicine.

Dr. Werbel is a physician-scientist who provides consultative care for patients at Johns Hopkins who experience infectious disease complications before and after organ transplant, as well as in the setting of solid tumors or blood cancers. His research with the Johns Hopkins Transplant Research Center uses a combination of epidemiological and laboratory methods to better personalize the prevention of infectious complications among patients with complex immunodeficiencies. This includes using national cohort studies and clinical trials to optimize the use of vaccines and other prophylactic therapies for high-risk immunosuppressed populations. Dr. Werbel is rated as a Distinguished provider by MediFind in the treatment of COVID-19. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses COVID-19, Severe Acute Respiratory Syndrome (SARS), HIV/AIDS, and Hepatitis. Dr. Werbel is board certified in American Board Of Internal Medicine.

Dr. Nisha A. Gilotra is a cardiologist in the Johns Hopkins Medicine Division of Cardiology with expertise in advanced heart failure, including the care of heart transplant and ventricular assist device patients. Dr. Gilotra specializes in inflammatory cardiomyopathies, including sarcoidosis, myocarditis and inherited causes of cardiomyopathy. Dr. Gilotra received her medical degree from Jefferson Medical College in Philadelphia, PA. She completed her medical residency, general cardiology fellowship and advanced heart failure fellowship at Johns Hopkins University School of Medicine. Between fellowships, she served as an Assistant Chief of Service for the Department of Medicine. Dr. Gilotra is rated as an Advanced provider by MediFind in the treatment of COVID-19. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Sarcoidosis, Myocarditis, Cardiomyopathy, Heart Transplant, and Endoscopy.

Olivia Kates is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Kates is rated as an Advanced provider by MediFind in the treatment of COVID-19. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses COVID-19, Diphtheria, Severe Acute Respiratory Syndrome (SARS), and Listeriosis. Dr. Kates is board certified in American Board Of Internal Medicine.

Dr. Anum Minhas attended medical school at Duke University and trained in internal medicine at the University of Michigan, Ann Arbor. During her Cardiology fellowship training at Johns Hopkins University School of Medicine, she served as the Chief Cardiology fellow and was honored to receive the Marie-Josee and Henry R. Kravis Endowed Fellowship and the Lou and Nancy Grasmick Endowed Research Fellowship (2021-2022). She was also awarded the Dlabal Clinical Research award for originality and creativity in research. During her fellowship, she completed additional training and obtained a Master of Health Science with focus in cardiovascular epidemiology as an NIH T32 postdoctoral fellow at the Johns Hopkins Bloomberg School of Public Health. She also completed additional clinical training during fellowship in Advanced Echocardiography, and designed and completed an inaugural fellowship in Cardio-Obstetrics. Dr. Minhas joined the Johns Hopkins Cardiology faculty with a clinical focus in women's cardiovascular health, specifically Cardio-Obstetrics, or cardiac disease around pregnancy. She also attends in the coronary critical care unit and the echocardiography laboratory. She was selected as a recipient of an NIH-sponsored KL2 award through the Clinical Research Scholars Program. Her current research focuses on preventing and managing cardiovascular disease associated with pregnancy complications, such as preeclampsia. She is the recipient of several grants and has coauthored multiple publications and book chapters in women's cardiovascular health. She hopes to use her research to raise awareness of and provide insights into mechanisms of pregnancy-associated cardiac disease and promote health equity in maternal health. Videos Community ConversationMaternal Health Recent News Articles and Media Coverage https://the1a.org/segments/in-good-health-unpacking-heart-disease-in-women/ In Good Health: Medical missteps for women with heart disease, NPR Podcast. Dr. Minhas is rated as an Advanced provider by MediFind in the treatment of COVID-19. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Peripartum Cardiomyopathy, Pulmonary Edema, COVID-19, and Cardiomyopathy. Dr. Minhas is board certified in American Board Of Internal Medicine.

John Baddley is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Baddley is rated as an Advanced provider by MediFind in the treatment of COVID-19. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Cryptococcosis, Shingles, Sepsis, and Febrile Neutropenia. Dr. Baddley is board certified in American Board Of Internal Medicine.

Dr. Annie Antar is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include internal medicine and infectious diseases. Her areas of research expertise include long COVID, long COVID in people living with HIV, HIV cure, and suboptimal CD4 response after antiretroviral therapy. Dr. Antar earned her undergraduate degree from Harvard University and her M.D. and Ph.D. degrees from Vanderbilt University School of Medicine. She completed both her residency in internal medicine and fellowship in infectious diseases at the Johns Hopkins Hospital. Dr. Antar is rated as an Advanced provider by MediFind in the treatment of COVID-19. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Long Haul COVID, Severe Acute Respiratory Syndrome (SARS), COVID-19, and HIV/AIDS. Dr. Antar is board certified in American Board Of Internal Medicine.

Kathleen Neuzil is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Neuzil is rated as a Distinguished provider by MediFind in the treatment of COVID-19. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Typhoid Fever, Salmonella Enterocolitis, Flu, and COVID-19.

Dr. Nate Permpalung is an Associate Professor of Medicine and serves as the Director of Mycology Research in the Division of Infectious Diseases and Associate Director for Clinical Trials of Transplant Research Center at Johns Hopkins University School of Medicine. In his capacity as a Transplant Infectious Disease physician at Johns Hopkins Hospital, he provides specialized care to immunocompromised patients, including those who have undergone solid organ transplants and those undergoing cancer treatment. His research focuses are respiratory viral infections, invasive fungal infections, fungal-viral interactions, fungal diagnostics, and human pythiosis. Nationally, Dr. Permpalung has served on the panel for the IDSA Aspergillosis Guidelines development and has held editorial positions as Associate Editor for Medical Mycology and as an Editorial Board Member for the Journal of Heart and Lung Transplantation Open. Dr. Permpalung is rated as an Advanced provider by MediFind in the treatment of COVID-19. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Pneumocystis Jiroveci Pneumonia, COVID-19, Febrile Neutropenia, and Respiratory Syncytial Virus (RSV) Infection. Dr. Permpalung is board certified in American Board Of Internal Medicine.

Dr. Gregory Kirk is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in oncology and, at the Johns Hopkins Bloomberg School of Public Health, in epidemiology. His areas of clinical expertise include epidemiology, hepatitis, HIV, AIDS and infectious diseases. He serves as the vice chair for clinical and translational research at the Johns Hopkins School of Medicine. Dr. Kirk received his undergraduate degree from Oklahoma State University. He earned a Ph.D. and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He earned his M.D. from the University of Oklahoma Health Sciences Center College of Medicine. He completed a residency in preventative medicine at the Johns Hopkins Bloomberg School of Public Health and in internal medicine at Georgetown University. He performed a fellowship in infectious diseases at the National Institute of Allergy and Infectious Diseases. His research focuses on understanding and preventing the long-term consequences of chronic HIV infection, particularly the malignant complications of HIV and viral hepatitis. He has extensive research and clinical experience in Africa, leading the Gambia Liver Cancer Study, one of the largest studies of hepatocellular carcinoma (HCC) performed in the continent, in addition to years of collaborative research in Uganda. Dr. Kirk pioneered the use of elastography and application of novel aflatoxin-associated biomarkers of HCC risk to be applied in Consortium projects. He has strong, multidisciplinary team leadership skills as principal investigator of the ALIVE cohort and several other collaborative studies in Baltimore. Dr. Kirk is rated as an Advanced provider by MediFind in the treatment of COVID-19. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Hepatitis C, Hepatitis, and COVID-19. Dr. Kirk is board certified in American Board Of Internal Medicine.

Dr. Kelly Gebo is a graduate of The Johns Hopkins University School of Medicine. She also earned an MPH in Epidemiology from The Johns Hopkins Bloomberg School of Public Health. She completed residency training in Internal Medicine at The Johns Hopkins Hospital followed by an infectious diseases fellowship and two additional years of fellowship training as a Robert Wood Johnson Clinical Scholar, also at Hopkins. Her clinical and research interests include clinical outcomes and healthcare utilization research within infectious diseases. She was Director of the JHU Public Health Studies Program between the Krieger School for Arts and Sciences and the Bloomberg School for Public Health, was an American Council of Education Fellow (hosted at the University of Pennsylvania) and was the inaugural Vice Provost for Education at Johns Hopkins. She was on sabbatical at Stanford University School of Medicine 2019-20 and served as the Chief Medical and Scientific Officer for the All of Us Research Program 2018-2020. She currently serves as the director of the Johns Hopkins Clinical Research Scholars Program and is Deputy Director of the Johns Hopkins Institute for Clinical and Translational Research. She has mentored undergraduate, public health and medical students, trainees, and junior faculty on infectious diseases and health services projects. She has authored or co-authored numerous chapters and over 250 papers. She is a member of the American Society of Clinical Investigation and has been awarded the David Levine Prize for mentoring at Johns Hopkins. LinkedIn https://www.linkedin.com/in/kelly-gebo-13377811/. Dr. Gebo is rated as an Advanced provider by MediFind in the treatment of COVID-19. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex. Dr. Gebo is board certified in American Board Of Internal Medicine.

Dr. Yukari Manabe is a Professor in the Division of Infectious Diseases in the Department of Medicine with secondary appointments in the Bloomberg School of Public Health Department of International Health and the Department of Microbiology and Molecular Immunology. Dr. Manabe began her career working on the basic science aspects of tuberculosis (TB) immunopathogenesis in comparative animal models of infection, particularly latency, reactivation, and immune reconstitution inflammatory syndrome (IRIS) in the rabbit model within the Johns Hopkins Center for Tuberculosis Research. In 2007, she was seconded to the Infectious Diseases Institute (IDI) at Makerere College of Health Sciences as the Associate Medical Laboratory Director of the College of American Pathologists certified Makerere University-Johns Hopkins University Clinical Core Lab to study antiretroviral associated TB and IRIS. She then became the Head of Research at the IDI in 2008 until 2012 where she built research capacity and infrastructure to train Ugandan investigators. Since returning to Hopkins, she has become the PI of the Johns Hopkins POC STD Center (U54 funded through NIH) which is part of the newly formed Johns Hopkins Center for Innovative Diagnostics for Infectious Diseases. The Center develops new diagnostics, funds development for point-of-care diagnostics, evaluates (validation and verification) new technology, and performs pre-clinical studies to accelerate the development of infectious disease assays (STIs, TB, acute febrile illness, HIV, syphilis, viral hepatitis). Dr. Manabe is particularly interested in rapid, point-of-care infectious disease diagnostics suitable for the resource-limited settings particularly in sub-Saharan Africa (SSA). Her research has focused on accuracy testing of various rapid, point-of-care diagnostics for HIV and related infectious diseases of clinical importance in SSA. Studies have ranged from evaluations of performance accuracy through clinical implementation science studies on the patient-centered outcomes and impactful use of new rapid diagnostics. Dr. Manabe obtained her undergraduate degree from Yale University and her M.D. from Columbia University College of Physicians and Surgeons. After completing both her residency in Internal Medicine and fellowship in Infectious Diseases at Johns Hopkins Hospital, she joined the faculty in 1999. Dr. Manabe is rated as an Advanced provider by MediFind in the treatment of COVID-19. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, Gonorrhea, Cryptococcosis, Meningitis, and Tissue Biopsy.

Dr. Bailey received his M.D. and Ph.D. degrees from the Johns Hopkins University School of Medicine through the Medical Scientist Training Program and completed medical residency at the Massachusetts General Hospital. He subsequently completed fellowship training in Infectious Diseases at the Johns Hopkins University School of Medicine before transitioning to a faculty position. His primary clinical interests are management and treatment of HIV and viral hepatitis, including hepatitis c virus. His research interests include the study of human B cells and neutralizing antibody responses against hepatitis C virus (HCV), hepatitis B virus (HBV), SARS-CoV-2, and respiratory syncytial virus (RSV), with the goal of developing improved vaccines against these viruses. Dr. Bailey is rated as an Advanced provider by MediFind in the treatment of COVID-19. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Hepatitis C, COVID-19, Hepatitis, and Long Haul COVID. Dr. Bailey is board certified in American Board Of Internal Medicine.

Thomas Cudjoe is a primary care provider, practicing in Geriatrics in Baltimore, Maryland. Dr. Cudjoe is rated as an Advanced provider by MediFind in the treatment of COVID-19. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses COVID-19, Severe Acute Respiratory Syndrome (SARS), and Dementia. Dr. Cudjoe is board certified in American Board Of Internal Medicine.

Dr. Galiatsatos is a pulmonary and critical care medicine physician. He is an expert in the diagnosis and treatment of obstructive lung disease, tobacco cessation, and in the care of critically ill patients in the Medical ICU. He is a member of the Obstructive Lung Disease Group at Johns Hopkins, oversees the Tobacco Treatment Clinic and provides teaching to medical students and residents at Johns Hopkins. Dr. Galiatsatos is rated as an Advanced provider by MediFind in the treatment of COVID-19. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Pulmonary Arteriovenous Fistula, Chronic Obstructive Pulmonary Disease (COPD), COVID-19, and Severe Acute Respiratory Syndrome (SARS). Dr. Galiatsatos is board certified in American Board Of Internal Medicine.

Dr. Allison L. Agwu, MD, ScM, FAAP, FIDSA is Professor of pediatric and adult infectious diseases at the Johns Hopkins University School of Medicine. Her clinical interests include HIV/AIDS and infectious disease. Dr. Agwu earned her medical degree from the University of Maryland School of Medicine. She completed a residency in pediatrics and internal medicine at Case Western Reserve University (University Hospitals of Cleveland/ Rainbow Babies and Children’s Hospital), and a combined fellowship in pediatric and adult infectious diseases at the Johns Hopkins School of Medicine. Dr. Agwu's clinical and research interests focuses on children, adolescents, and young adults who are at-risk or living with HIV and their families. Clinically, she provides inpatient and outpatient pediatric infectious diseases' consultations and leads the Pediatric Adolescent HIV/AIDS Program, which provides multidisciplinary for those living with or affected by HIV. Further, she leads the young adult transition clinic, the Accessing Care Early (ACE) Clinic. Both programs are longstanding Ryan White Federal Grant-funded programs. Her overarching research goal is to decipher, address, and minimize disparities in treatment and outcomes for those living with HIV. Toward this goal, she oversees her own independent, longstanding, federally funded clinical research program and serves as principal investigator of the Johns Hopkins sites of the International Maternal, Pediatric, and Adolescent AIDS Clinical Trials (IMPAACT) Network and the Adolescent Trials' Network (ATN). Her research interests include optimizing outcomes for youth at-risk for and living with HIV, management and treatment strategies, and minimizing disparities in the use of antiretroviral therapy (ART) and outcomes. Other special interests include epidemiologic approaches to HIV, drug resistance, and clinical trials. She is a member of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. Dr. Agwu is Chair of the HIV Medicine Association. Dr. Agwu is rated as an Experienced provider by MediFind in the treatment of COVID-19. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, Gonorrhea, Chlamydia, and COVID-19. Dr. Agwu is board certified in American Board Of Pediatrics.

Amita Gupta is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Gupta is rated as an Experienced provider by MediFind in the treatment of COVID-19. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex. Dr. Gupta is board certified in American Board Of Internal Medicine.

Dr. Stephen D. Sisson is a professor of medicine at the Johns Hopkins University School of Medicine. Dr. Sisson’s area of clinical expertise is internal medicine. He serves as vice president of clinical operations for the Office of Johns Hopkins Physicians, and as director of the Johns Hopkins Physician Education and Assessment Center (PEAC). He is the Philip A. Tumulty Professor of Medicine. Dr. Sisson holds a B.S. in chemistry from Duke University. He earned his M.D. (Alpha Omega Alpha, with research honors) at Tufts University School of Medicine. He completed an internal medicine internship and residency at Johns Hopkins, serving as assistant chief of service for the Barker Firm. He joined the Johns Hopkins faculty in 1996. He served for 15 years as the associate director of the Osler Medical Housestaff Training Program. His research interests include community outreach, medical education and ambulatory care. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Sisson is rated as an Experienced provider by MediFind in the treatment of COVID-19. His clinical expertise encompasses COVID-19, Cerebral Palsy, Hypereosinophilic Syndrome, and Acute Eosinophilic Pneumonia. Dr. Sisson is board certified in American Board Of Internal Medicine.

Kavita Sharma MD, is an Associate Professor of Medicine in Advanced Heart Failure/Transplant Cardiology in the Division of Cardiology at the Johns Hopkins University School of Medicine. She is the Director of the Johns Hopkins Heart Failure with Preserved Ejection Fraction Program. She sees patients at The Johns Hopkins Hospital, downtown campus. A cardiologist specializing in advanced heart failure, her clinical interests include advanced heart failure diagnosis and management, heart transplantation, and mechanical circulatory support including left ventricular assist devices. She has a specialized interest in heart failure with preserved ejection fraction (HFpEF), and directs one of the largest programs in the country dedicated to caring for patients with this condition. She is the principal investigator of numerous clinical and translational trials in HFpEF and leads a team of nurses, research coordinators, and fellows-in-training in this multi-faceted program. She is an invited speaker at national meetings in topic areas covering advanced heart failure and HFpEF. Dr. Sharma is a member of the American Heart Association, the American College of Cardiology, the Heart Failure Society of America, and the International Society of Heart and Lung Transplantation. Dr. Sharma is rated as an Experienced provider by MediFind in the treatment of COVID-19. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Cardiac Amyloidosis, Heart Transplant, and Tissue Biopsy. Dr. Sharma is board certified in American Board Of Internal Medicine.